NAUTILUS BIOTECHNOLOGY INC's ticker is NAUT and the CUSIP is 63909J108. A total of 75 filers reported holding NAUTILUS BIOTECHNOLOGY INC in Q1 2023. The put-call ratio across all filers is 443.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $4 | -20.0% | 1,654 | 0.0% | 0.00% | – |
Q1 2024 | $5 | -61.5% | 1,654 | -62.7% | 0.00% | – |
Q4 2023 | $13 | -18.8% | 4,439 | -10.0% | 0.00% | – |
Q3 2023 | $16 | -15.8% | 4,931 | 0.0% | 0.00% | – |
Q2 2023 | $19 | +35.7% | 4,931 | 0.0% | 0.00% | – |
Q1 2023 | $14 | +27.3% | 4,931 | -18.3% | 0.00% | – |
Q4 2022 | $11 | -99.9% | 6,035 | 0.0% | 0.00% | – |
Q3 2022 | $13,000 | -18.8% | 6,035 | 0.0% | 0.00% | – |
Q2 2022 | $16,000 | – | 6,035 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AH Equity Partners Bio II, L.L.C. | 16,298,006 | $43,842,000 | 30.79% |
Madrona Venture Group, LLC | 6,020,770 | $16,196,000 | 7.52% |
AH Equity Partners LSV II, L.L.C. | 1,355,911 | $3,647,000 | 3.82% |
Ally Bridge Group (NY) LLC | 1,080,566 | $2,907,000 | 2.65% |
Tikvah Management LLC | 1,488,895 | $4,005,000 | 1.73% |
ArchPoint Investors | 1,449,551 | $3,899,000 | 1.54% |
Perceptive Advisors | 9,111,151 | $24,508,000 | 0.77% |
Bain Capital Life Sciences Investors, LLC | 2,000,000 | $5,380,000 | 0.63% |
CROWN ADVISORS MANAGEMENT, INC. | 250,000 | $672,000 | 0.62% |
Affinity Asset Advisors, LLC | 466,607 | $1,255,000 | 0.53% |